Search Results - Samaras, Christy Joy

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case series

    Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case series by Atieh, Tahani, Hubben, Anne, Faiman, Beth, Valent, Jason, Samaras, Christy Joy, Khouri, Jack

    Published in Annals of hematology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    An Advanced Practice Provider-led, Outpatient Consult Clinic for Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Plasma Cell Disorders (PCDs): The Cleveland Clinic Experience

    An Advanced Practice Provider-led, Outpatient Consult Clinic for Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Plasma Cell Disorders (PCDs): The Cleve... by Faiman, Beth, Hamilton, Kimberly, Khouri, Jack, Valent, Jason, Mejia-Garcia, Alex, Samaras, Christy Joy

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Real World Data on the Safety and Efficacy of Pomalidomide as a Single Agent and in Combination with Corticosteroids in Relapsed and Refractory Multiple Myeloma

    Real World Data on the Safety and Efficacy of Pomalidomide as a Single Agent and in Combination with Corticosteroids in Relapsed and Refractory Multiple Myeloma by Atieh, Tahani, Hubben, Anne, Wei, Wei, Faiman, Beth, Samaras, Christy Joy, Valent, Jason, Khouri, Jack

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Lenalidomide-Related Diarrhea Correlates with Disease Control in Newly-Diagnosed Patients with Multiple Myeloma

    Lenalidomide-Related Diarrhea Correlates with Disease Control in Newly-Diagnosed Patients with Multiple Myeloma by Faiman, Beth, Kalaycio, Matt, Samaras, Christy Joy, Khouri, Jack, Anwer, Faiz, Mejia-Garcia, Alex, Reu, Frederic, Valent, Jason

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma

    A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma by Khouri, Jack, Faiman, Beth, Wei, Wei, Grabowski, Dale, Samaras, Christy Joy, mahfouz, Reda, Lazarus, Hillard, Dean, Robert, Malek, Eshan, Reed, Janice, Karam, Mary Ann, Hamilton, Kimberly, Rosko, Nathaniel, Fada, Sherry, Kalaycio, Matt, Liu, Hien, Saunthararajah, Yogen, Chew, Yap, Valent, Jason, Reu, Frederic

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients

    Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients by Reece, Donna, Bahlis, Nizar J., Samaras, Christy Joy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald, Anz, Bertrand, Fonseca, Gustavo, Agarwal, Amit, Chung, Weiyuan, Zafar, Faiza, Siegel, David S.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: